DiscoverTech DisruptorsGSK’s Use of AI in Vaccine Tech, Drug Discovery
GSK’s Use of AI in Vaccine Tech, Drug Discovery

GSK’s Use of AI in Vaccine Tech, Drug Discovery

Update: 2024-05-30
Share

Description

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Technology Analyst Mandeep Singh are hosts.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

GSK’s Use of AI in Vaccine Tech, Drug Discovery

GSK’s Use of AI in Vaccine Tech, Drug Discovery

Bloomberg